ALMIRALL, LLC

FDA Regulatory Profile

ALMIRALL, LLC appears in FDA public data with 1 recall, 0 510(k) clearances, 3 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-1549-2022, Class III) was initiated on September 16, 2022.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
3
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-1549-2022Class IIIXolegel (ketoconazole) gel 2%, 45 gram tubes, Rx only, Manufactured by: DPT Laboratories, San AntoniSeptember 16, 2022